Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome

Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome

NLR family pyrin domain containing 3 (NLRP3) inflammasome accompanies chronic liver injury and is a critical mediator of inflammation-driven liver fibrosis. Sphingosine 1-phosphate (S1P)/S1P Receptor (S1PR) signaling participates in liver fibrogenesis by affecting bone marrow (BM)-derived monocytes/...

Full description

Bibliographic Details
Main Authors:	Lei Hou, Le Yang, Na Chang, Xinhao Zhao, Xuan Zhou, Chengbin Dong, Fuquan Liu, Lin Yang, Liying Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Series:	Frontiers in Immunology
Subjects:	macrophage NLR family pyrin domain-containing 3 inflammation sphingosine 1-phosphate S1P receptor 2 liver injury
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01149/full

Similar Items

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
by: Kana Masuda-Kuroki, et al.
Published: (2023-09-01)

Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
by: Sara Grassi, et al.
Published: (2019-07-01)

Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface
by: Kana Masuda-Kuroki, et al.
Published: (2022-05-01)

Sphingosine 1-Phosphate Receptor 4 Expression in Colorectal Cancer Patients
by: Suchittra SAMUHASANEETO, et al.
Published: (2016-06-01)

Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases
by: Na Wang, et al.
Published: (2023-05-01)

Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study
by: Katrin G. Schmidt, et al.
Published: (2017-09-01)

Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice
by: Ruixue Zhang, et al.
Published: (2019-09-01)

Roles of sphingosine-1-phosphate signaling in cancer
by: Peng Wang, et al.
Published: (2019-11-01)

Neurological Consequences of Sphingosine Phosphate Lyase Insufficiency
by: Krishan B. Atreya, et al.
Published: (2022-09-01)

Up-regulation of microRNA-135 or silencing of PCSK6 attenuates inflammatory response in preeclampsia by restricting NLRP3 inflammasome
by: Xiaolan Zhao, et al.
Published: (2021-07-01)

Tanshinone IIA ameliorates myocardial ischemia/reperfusion injury in rats by regulation of NLRP3 inflammasome activation and Th17 cells differentiation
by: Dan Li, et al.
Published: (2022-10-01)

HIV-1 Infection Results in Sphingosine-1-Phosphate Receptor 1 Dysregulation in the Human Thymus
by: Rachel S. Resop, et al.
Published: (2023-09-01)

Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease[S]
by: Julie D. Saba
Published: (2019-03-01)

NLRP3 inflammasome inhibitor MCC950 can reduce the damage of pancreatic and intestinal barrier function in mice with acute pancreatitis
by: Yanghui Shen, et al.
Published: (2022-10-01)

Sphingosine kinase/sphingosine 1-phosphate axis: a new player for insulin-like growth factor-1-induced myoblast differentiation
by: Bernacchioni Caterina, et al.
Published: (2012-07-01)

Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction
by: Shahzad Nawaz Syed, et al.
Published: (2020-07-01)

Role of Sphingosine-1-Phosphate in Mast Cell Functions and Asthma and Its Regulation by Non-Coding RNA
by: Rohit Saluja, et al.
Published: (2017-05-01)

A Sphingosine 1-Phosphate Gradient Is Linked to the Cerebral Recruitment of T Helper and Regulatory T Helper Cells during Acute Ischemic Stroke
by: Alexandra Lucaciu, et al.
Published: (2020-08-01)

Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer
by: Saida Mebarek, et al.
Published: (2023-05-01)

Irisin Is Target of Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor-Mediated Signaling in Skeletal Muscle Cells
by: Federica Pierucci, et al.
Published: (2023-06-01)

Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study
by: Jiangnan Zhao, et al.
Published: (2020-04-01)

Inhibition of the NLRP3/IL‐1β axis protects against sepsis‐induced cardiomyopathy
by: Katharina Busch, et al.
Published: (2021-12-01)

Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer
by: Petra Grbčić, et al.
Published: (2020-05-01)

Sphingosine 1-Phosphate and Cancer: Lessons from Thyroid Cancer Cells
by: Kid Törnquist
Published: (2013-05-01)

The Anti-Infectious Role of Sphingosine in Microbial Diseases
by: Yuqing Wu, et al.
Published: (2021-05-01)

Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
by: Sabira Mohammed, et al.
Published: (2018-07-01)

Commentary: Sphingosine-1-phosphate inhibitors are potential therapeutic targets for pulmonary arterial hypertension
by: Naga P Bhavanam, et al.
Published: (2015-10-01)

Inflammasomes—New Contributors to Blood Diseases
by: Jaromir Tomasik, et al.
Published: (2022-07-01)

Puerarin protects renal ischemia-reperfusion injury in rats through NLRP3/Caspase-1/GSDMD pathway
by: Kangyu Wang, et al.
Published: (2023-12-01)

Does the Sphingosine 1-Phosphate Receptor-1 Provide a Better or Worse Prognostic Outcome for Breast Cancer Patients?
by: Nigel J. Pyne, et al.
Published: (2018-09-01)

Sphingosine-1 Phosphate Lyase Regulates Sensitivity of Pancreatic Beta-Cells to Lipotoxicity
by: Yadi Tang, et al.
Published: (2021-10-01)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
by: Alessandro Cannavo, et al.
Published: (2017-08-01)

Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils
by: Makiko Yashiro Furuya, et al.
Published: (2018-08-01)

Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review
by: Rosa Direito, et al.
Published: (2023-06-01)

Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages via TWIK2-mediated potassium efflux
by: Yingqin Wang, et al.
Published: (2023-01-01)

Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival
by: Rosaria Bassi, et al.
Published: (2021-06-01)

Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
by: Stanley Cohan, et al.
Published: (2020-07-01)

Sphingosine 1-Phosphate in Malaria Pathogenesis and Its Implication in Therapeutic Opportunities
by: Gunanidhi Dhangadamajhi, et al.
Published: (2020-08-01)

Sphingosine Kinase Blockade Leads to Increased Natural Killer T Cell Responses to Mantle Cell Lymphoma
by: Michael S. Lee, et al.
Published: (2020-04-01)

Effects of 1,25-dihydroxyvitamin D3 on experimental periodontitis and AhR/NF-κB/NLRP3 inflammasome pathway in a mouse model
by: Hao Li, et al.
Published: (2019-11-01)